Itemoids

You are not logged in so some information on this page has been withheld. To see more, please log in or sign up.

Doximity

since

auto-detected in 7 stories

74 days ago

Morgan Stanley sees shares of Doximity rising 48% from here.

6 months ago

Pathway's AI-powered clinical reference tool helps doctors answer questions about guidelines, drugs and trials.
AstraZeneca's CEO said the company has proposed U.S. price cuts to some drugs, while Doximity enters competitive AI scribing market with new free offering.

9 months ago

These are the stocks posting the largest moves in premarket trading.

12 months ago

The company built a digital platform for medical professionals that can help them carry out telehealth appointments with patients, find referrals and more.
Doximity reported third-quarter fiscal 2025 results that beat analysts' expectations for revenue and guidance.
Doximity reported third-quarter fiscal 2025 results that beat analysts' expectations for revenue and guidance.

page 1 of 1